In M&A news, Stada has nailed down a deal to buy the British OTC company Thorton & Ross for €259 million.
Stada said in a statement that the M&A news deal for about $345 million in cash and assumed debt will be closed by the end of the month.
Thorton & Ross will be contributing to Stada's bottom line on Sept. 1 as part of the M&A news deal.
The M&A news deal also gives Stada a little bit more heft with which to defend itself against potential takeover artists.
Report: Partnering Deals and Alliances with Stada
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity